Zhengye Biotechnology Holding Ltd
Research Zhengye Biotechnology Holding Ltd (ZYBT) on Bullrun: market cap USD 89.57M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerZYBT
- ExchangeNASDAQ
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 89.57M
- Financial periodFY2025
- RevenueCNY 16.64M
- Revenue growth-91.1%
- Net income-CNY 9.98M
- Free cash flowCNY 1.77M
- Gross margin20.5%
Valuation Snapshot
latest market cap is USD 89.57M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 16.64M | -CNY 9.98M | CNY 1.77M | 20.5% | n/a | CNY 7.20M | CNY 1.47M | CNY 35.72M |
| FY2024 | CNY 186.36M | CNY 11.31M | n/a | n/a | n/a | CNY 18.60M | CNY 86.43M | CNY 283.96M |
| FY2023 | CNY 211.65M | CNY 31.46M | n/a | n/a | n/a | CNY 15.07M | CNY 89.85M | CNY 272.85M |
| FY2022 | CNY 260.27M | CNY 46.74M | n/a | n/a | n/a | n/a | n/a | n/a |
| FY2021 | CNY 214.07M | CNY 38.96M | n/a | n/a | n/a | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 89.57M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 54.50M | n/a | n/a | n/a |
About Zhengye Biotechnology Holding Ltd
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Zhengye Biotechnology Holding Ltd's market cap?
Zhengye Biotechnology Holding Ltd's market capitalization is USD 89.57M.
What does Zhengye Biotechnology Holding Ltd do?
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt.